I got some clarification from Joe, and the call will be helpful to get a better understanding of what’s taking place to improve the MSO.
He takes strong issue about my comment on the due diligence. They used 4 law firms, an investment bank, plus others, and work on auditing the financials to do a thorough job.
“The MSO is the most valuable thing we have period, owning a dr network can be turned on and off any time, when turned on drs prescribe and sell your stuff period, turned off they don’t. We have had to change things totally from a partnership and stock ownership from a cash payout system that takes longer then two quarters, big deal, when it gets turned back on it makes big money again. We just won’t have to deal with stark laws ever again under our new restructure, but dealing with converting 600 drs takes longer then 5 mos with every one having new docs and their own lawyers weighing in.”
It all makes sense, I just didn’t realize that Generex was revamping the MSO, and thought it was turn-key ready to a greater extent.
“If we tell doctors to stop we are changing things and making them better then until it’s a more compliant structure it goes on pause- same as a car. I buy a Ferrari and want to lower the front and put crash plates underneath and add 400 more horses. And I do it. It means it doesn’t get driven until done, but for sure does not mean the Ferrari is worth any less then I bought it. On the contrary, with those enhancements I just made it much more valuable... changing it could take a month or 6 mos depending on others. And here there are over 12oo others including a lawyer for each doctor, does not mean when it’s done each doctor doesn’t revenue like before, except now they have new stuff like Excellagen.”
I should have asked before spouting off, but the company could also explain that better leading into the last two quarterly reports that left us wondering. Generex has a lot coming together here so let’s listen closely to let it all sink in. I certainly want to see GNBT viewed as a Ferrari!
He takes strong issue about my comment on the due diligence. They used 4 law firms, an investment bank, plus others, and work on auditing the financials to do a thorough job.
“The MSO is the most valuable thing we have period, owning a dr network can be turned on and off any time, when turned on drs prescribe and sell your stuff period, turned off they don’t. We have had to change things totally from a partnership and stock ownership from a cash payout system that takes longer then two quarters, big deal, when it gets turned back on it makes big money again. We just won’t have to deal with stark laws ever again under our new restructure, but dealing with converting 600 drs takes longer then 5 mos with every one having new docs and their own lawyers weighing in.”
It all makes sense, I just didn’t realize that Generex was revamping the MSO, and thought it was turn-key ready to a greater extent.
“If we tell doctors to stop we are changing things and making them better then until it’s a more compliant structure it goes on pause- same as a car. I buy a Ferrari and want to lower the front and put crash plates underneath and add 400 more horses. And I do it. It means it doesn’t get driven until done, but for sure does not mean the Ferrari is worth any less then I bought it. On the contrary, with those enhancements I just made it much more valuable... changing it could take a month or 6 mos depending on others. And here there are over 12oo others including a lawyer for each doctor, does not mean when it’s done each doctor doesn’t revenue like before, except now they have new stuff like Excellagen.”
I should have asked before spouting off, but the company could also explain that better leading into the last two quarterly reports that left us wondering. Generex has a lot coming together here so let’s listen closely to let it all sink in. I certainly want to see GNBT viewed as a Ferrari!
